Nomura Holdings
MIRM icon

Nomura Holdings’s Mirum Pharmaceuticals MIRM Stock Holding History

Nomura Holdings’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,600
Closed -$924K – 2056
2025
Q3 		$924K Hold
12,600
– – ﹤0.01% 1421
2025
Q2 		$641K Hold
12,600
– – ﹤0.01% 1089
2025
Q1 		$568K Buy
+12,600
New +$594K ﹤0.01% 1446
2024
Q4 		– Sell
-20,000
Closed -$780K – 2313
2024
Q3 		$780K Hold
20,000
– – ﹤0.01% 1171
2024
Q2 		$684K Buy
+20,000
New +$524K ﹤0.01% 1240

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Nomura Holdings's MIRM Position: Q1 2026 in Review

Nomura Holdings increased its Mirum Pharmaceuticals (MIRM) stake by 98% in Q1 2026, buying an estimated $915K and bringing the position to 19,598 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #962.

Nomura Holdings first reported a position in MIRM in Q4 2025 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Nomura Holdings held 19,598 shares of Mirum Pharmaceuticals worth $1.81M as of Q1 2026.
  • Nomura Holdings bought 9,722 Mirum Pharmaceuticals shares in Q1 2026, an estimated $915K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #962 holding.
  • Nomura Holdings first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.